v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 4,794,070 $ 8,781,059
Advances and deposits on clinical programs and other current assets 1,826,815 1,942,685
Total current assets 6,620,885 10,723,744
Property and equipment (at cost, less accumulated depreciation and amortization) 459,936 529,936
Other assets:    
Operating lease right-of-use assets, net 887,892 984,436
Deposits and other assets 50,000 50,000
Total other assets 937,892 1,034,436
Total assets 8,018,713 12,288,116
Current liabilities:    
Accounts payable – trade 964,590 1,392,829
Other accrued liabilities 2,782,740 2,824,646
Operating lease liability - current portion 418,903 406,354
Total current liabilities 4,166,233 4,623,829
Operating lease liability - non-current portion 492,849 602,411
Total liabilities 4,659,082 5,226,240
Commitments and contingencies
Stockholders’ equity:    
Preferred stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at March 31, 2026 and December 31, 2025
Common stock - $0.01 par value (350,000,000 shares authorized; 3,922,766 and 3,419,652 shares issued at March 31, 2026 and December 31, 2025, respectively; and 3,922,764 and 3,419,650 shares outstanding at March 31, 2026 and December 31, 2025, respectively) 39,228 34,197
Additional paid-in capital 428,952,685 428,410,939
Accumulated deficit (425,547,094) (421,298,072)
Total stockholders’ equity before treasury stock 3,444,819 7,147,064
Treasury stock, at cost (2 shares at March 31, 2026 and December 31, 2025) (85,188) (85,188)
Total stockholders’ equity 3,359,631 7,061,876
Total liabilities and stockholders’ equity $ 8,018,713 $ 12,288,116